ぺ ニス 増大 カマグラ ed 治療 薬 性病 症状 性病 症状 睡眠薬 シルデナフィル ぺ ニス 増大 サプリ カマグラ ゴールド ぺ ニス 増大
VOGLOYD
Composition Voglibose 0.3/0.2 mg
Indication Diabetes mellitus
Mechanism of Action

Voligbose has general properties similar to acarbose and selectively inhibits α-glucosidase in the enteric canal, delaying the digestion and absorption of carbohydrate, thereby suppressing sharp increase in post-prandial plasma glucose.

Pharmacokinetic's

Absorption: voglibose is poorly absorbed after oral administration. However, systematic adverse effects have been observed.

Metabolism: the metabolism of voglibose in liver is negligible

Excretion: The renal excretion is negligible and plasma concentations after oral dose have been undetectable.

Side effects

Flatulence; abdominal distension; diarrhoea; pain; skin reactions;

hypoglycemia; increased LFT.

Potentially Fatal: Hepatotoxicity

Precaution

History of laparotomy or ileus. Roemheld's syndrome, stenosis, severe hepatic or renal impairment. Child <18 yr; elderly. Monitor LFT. Treat hypoglycaemic episodes with glucose (not with sucrose).

Dosage

Adult: 200-300 mcg Thrice a day.

Elderly: Initiate at lower doses.

nike cortez oakley chaussures de foot nike chaussure nike schuhe Scarpe Adidas superstar scarpe Nike Scarpe Cappelli chaussures femme Scarpe Cinture michael kors air max chaussure de sport christian louboutin nike air force schmuck chaussures sport